These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11396806)

  • 1. Markers of cystic fibrosis-associated liver disease.
    Narkewicz MR
    J Pediatr Gastroenterol Nutr; 2001 Apr; 32(4):421-2. PubMed ID: 11396806
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hepatobiliary disorders in cystic fibrosis].
    van de Meeberg PC; Bijleveld CM; Heijerman HG; Houwen RH; Sinaasappel M; van Berge Henegouwen GP
    Ned Tijdschr Geneeskd; 1994 Jul; 138(27):1357-60. PubMed ID: 8035893
    [No Abstract]   [Full Text] [Related]  

  • 3. Deletion delta F508 and clinical expression of cystic fibrosis-related liver disease.
    De Arce M; O'Brien S; Hegarty J; O'Mahoney SM; Cashman SM; Martinez A; Delgado M; FitzGerald MX
    Clin Genet; 1992 Nov; 42(5):271-2. PubMed ID: 1486703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of liver disease in cystic fibrosis.
    Scott-Jupp R; Lama M; Tanner MS
    Arch Dis Child; 1991 Jun; 66(6):698-701. PubMed ID: 2053791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome in cystic fibrosis liver disease.
    Rowland M; Gallagher CG; O'Laoide R; Canny G; Broderick A; Hayes R; Greally P; Slattery D; Daly L; Durie P; Bourke B
    Am J Gastroenterol; 2011 Jan; 106(1):104-9. PubMed ID: 20736939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural history of liver disease in cystic fibrosis.
    Lindblad A; Glaumann H; Strandvik B
    Hepatology; 1999 Nov; 30(5):1151-8. PubMed ID: 10534335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for the development of cystic fibrosis related liver disease.
    Slieker MG; Deckers-Kocken JM; Uiterwaal CS; van der Ent CK; Houwen RH
    Hepatology; 2003 Sep; 38(3):775-6; author reply 776-7. PubMed ID: 12939606
    [No Abstract]   [Full Text] [Related]  

  • 8. [Mucoviscidosis of the adult and liver insufficiency].
    Carboni M; Benedetti-Valentini F; Patrassi N
    Epatologia; 1970; 16(5):465-8. PubMed ID: 5525654
    [No Abstract]   [Full Text] [Related]  

  • 9. Liver disease and common-bile-duct stenosis in cystic fibrosis.
    Gaskin KJ; Waters DL; Howman-Giles R; de Silva M; Earl JW; Martin HC; Kan AE; Brown JM; Dorney SF
    N Engl J Med; 1988 Feb; 318(6):340-6. PubMed ID: 3340104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can biliary endoscopy play a role in liver disease associated to cystic fibrosis?
    Cantù P; Claut L; Elvevi A; Parzanese I; Maggioni M; Conte D; Penagini R; Colombo C
    J Cyst Fibros; 2015 Sep; 14(5):E21-3. PubMed ID: 26215754
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of ultrasound and biopsy findings in children with cystic fibrosis related liver disease.
    Mueller-Abt PR; Frawley KJ; Greer RM; Lewindon PJ
    J Cyst Fibros; 2008 May; 7(3):215-21. PubMed ID: 17904429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasonography of the pancreas, liver, and biliary system in cystic fibrosis.
    Wilson-Sharp RC; Irving HC; Brown RC; Chalmers DM; Littlewood JM
    Arch Dis Child; 1984 Oct; 59(10):923-6. PubMed ID: 6388511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver disease in cystic fibrosis.
    Leeuwen L; Fitzgerald DA; Gaskin KJ
    Paediatr Respir Rev; 2014 Mar; 15(1):69-74. PubMed ID: 23769887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of risk factors for the development of liver disease associated with cystic fibrosis.
    Colombo C; Apostolo MG; Ferrari M; Seia M; Genoni S; Giunta A; Sereni LP
    J Pediatr; 1994 Mar; 124(3):393-9. PubMed ID: 8120708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatobiliary disease in cystic fibrosis.
    Colombo C; Battezzati PM; Podda M
    Semin Liver Dis; 1994 Aug; 14(3):259-69. PubMed ID: 7939786
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum alpha-glutathione S-transferase as a sensitive marker of hepatocellular damage in patients with cystic fibrosis.
    Sídlová K; Skalická V; Kotaska K; Pechová M; Chada M; Bartosová J; Hríbal Z; Nevoral J; Vávrová V; Průsa R
    Physiol Res; 2003; 52(3):361-5. PubMed ID: 12790769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver disease and bile duct abnormalities in adults with cystic fibrosis.
    Nagel RA; Westaby D; Javaid A; Kavani J; Meire HB; Lombard MG; Wise A; Williams R; Hodson ME
    Lancet; 1989 Dec; 2(8677):1422-5. PubMed ID: 2574362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and genetic risk factors for cystic fibrosis-related liver disease.
    Wilschanski M; Rivlin J; Cohen S; Augarten A; Blau H; Aviram M; Bentur L; Springer C; Vila Y; Branski D; Kerem B; Kerem E
    Pediatrics; 1999 Jan; 103(1):52-7. PubMed ID: 9917439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary prognosis in cystic fibrosis patients with liver disease.
    Slieker MG; van der Doef HP; Deckers-Kocken JM; van der Ent CK; Houwen RH
    J Pediatr; 2006 Jul; 149(1):144; author reply 144-5. PubMed ID: 16860146
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term prospective study of the effect of ursodeoxycholic acid on cystic fibrosis-related liver disease.
    Nousia-Arvanitakis S; Fotoulaki M; Economou H; Xefteri M; Galli-Tsinopoulou A
    J Clin Gastroenterol; 2001 Apr; 32(4):324-8. PubMed ID: 11276276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.